×
FIRST-IN-CLASS, ORAL MUTANT IDH2 INHIBITOR REVERSES DIFFERENTIATION BLOCK IN ACUTE MYELOID LEUKAEMIA TO PRODUCE CLINICALLY MEANINGFUL RESPONSES
Vyas P.
Type
Conference paper
Publication Date
2017-01-01T00:00:00+00:00
Volume
53
Pages
S38 - S38